Cargando…
Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy
BACKGROUND: New treatment options are needed to maintain and improve therapy for tuberculosis, which caused the death of 1.5 million people in 2013 despite potential for an 86 % treatment success rate. A greater understanding of Mycobacterium tuberculosis (M.tb) bacilli that persist through drug the...
Autores principales: | Honeyborne, Isobella, McHugh, Timothy D., Kuittinen, Iitu, Cichonska, Anna, Evangelopoulos, Dimitrios, Ronacher, Katharina, van Helden, Paul D., Gillespie, Stephen H., Fernandez-Reyes, Delmiro, Walzl, Gerhard, Rousu, Juho, Butcher, Philip D., Waddell, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4825072/ https://www.ncbi.nlm.nih.gov/pubmed/27055815 http://dx.doi.org/10.1186/s12916-016-0609-3 |
Ejemplares similares
-
Pediatric tuberculosis-human immunodeficiency virus co-infection in the United Kingdom highlights the need for better therapy monitoring tools: a case report
por: Evangelopoulos, Dimitrios, et al.
Publicado: (2017) -
Culture-Free Enumeration of Mycobacterium tuberculosis in Mouse Tissues Using the Molecular Bacterial Load Assay for Preclinical Drug Development
por: Evangelopoulos, Dimitrios, et al.
Publicado: (2022) -
The Sputa in Phthisis
Publicado: (1858) -
Medicine: Rapid Method of Demonstrating Tubercle Bacilli in Sputa—Relapses in Typhoid Fever — The Diazo-Benzoic Reaction in Urine, &c.
por: Moir, D. M.
Publicado: (1894) -
THE SPECIFIC POLYSACCHARIDE CONTENT OF PNEUMONIC SPUTA
por: Tripp, J. T., et al.
Publicado: (1942)